Pancreatic Cancer Research

ResearcherNational University of SingaporeNo recent work listed

Pierce K. H. Chow

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0584-2584; OpenAlex author ID A5061027234. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2006: 1 trial · 2007: none · 2008: none · 2009: none · 2010: none · 2011: none · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 1

  1. Resected pancreatic adenocarcinoma: An Asian institution's experience. Co-author DOI 10.1002/cnr2.1393↗

Trials 1

  1. 32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer Principal investigator NCT00346281↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ye Xin Koh · 1 shared paper, 2021 · strength 0.10
  2. Kennedy Yao Yi Ng · 1 shared paper, 2021 · strength 0.10
  3. Ser Yee Lee · 1 shared paper, 2021 · strength 0.10
  4. Joycelyn Jie Xin Lee · 1 shared paper, 2021 · strength 0.10
  5. David Wai-Meng Tai · 1 shared paper, 2021 · strength 0.10
  6. Brian K. P. Goh · 1 shared paper, 2021 · strength 0.10
  7. Paul J. Ross · 1 shared trial, 2006 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.